- ¥5bn
- ¥12bn
- ¥11bn
- 22
- 76
- 47
- 46
Annual balance sheet for Enbio Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 2,015 | 2,372 | 2,829 | 3,604 | 3,293 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 948 | 1,594 | 792 | 1,270 | 2,354 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 6,616 | 6,459 | 7,318 | 8,246 | 8,958 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7,332 | 7,914 | 7,017 | 7,918 | 8,828 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 15,699 | 16,370 | 17,350 | 19,311 | 21,195 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,028 | 3,446 | 4,471 | 4,144 | 4,818 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 10,412 | 10,482 | 10,562 | 10,816 | 12,054 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 5,287 | 5,888 | 6,788 | 8,495 | 9,141 |
Total Liabilities & Shareholders' Equity | 15,699 | 16,370 | 17,350 | 19,311 | 21,195 |
Total Common Shares Outstanding |